Pelthos Therapeutics Inc. (PTHS) › Cost of RevenuePelthos Therapeutics Inc. (PTHS) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2024: $02025: $3.99M$3.99M2024Cost of Revenue (USD)2025Fiscal YearCost of RevenueChange YoY2025$3.99M—2024$0—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share